CAS 189939-61-5 | Hexadecanamide, N-(1-methylethyl)- | CAS Number 189939-61-5

200,000+ products from a single source!

sales@angenechem.com

Product Categories

Home > Other Building Blocks > 189939-61-5

189939-61-5 | Hexadecanamide, N-(1-methylethyl)-

CAS No: 189939-61-5 Catalog No: AG002E4W MDL No:MFCD04974481

Product Description

Catalog Number:

AG002E4W

Chemical Name:

Hexadecanamide, N-(1-methylethyl)-

CAS Number:

189939-61-5

Molecular Formula:

C19H39NO

Molecular Weight:

297.5191

MDL Number:

MFCD04974481

IUPAC Name:

N-propan-2-ylhexadecanamide

InChI:

InChI=1S/C19H39NO/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(21)20-18(2)3/h18H,4-17H2,1-3H3,(H,20,21)

InChI Key:

TZYVUGCYYQOTQR-UHFFFAOYSA-N

SMILES:

CCCCCCCCCCCCCCCC(=O)NC(C)C

Properties

Complexity:

226

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

297.303g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

297.527g/mol

Monoisotopic Mass:

297.303g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

29.1A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

7.7

Literature

Title	Journal
The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.	Life sciences 20060102
Fatty acid amide hydrolase controls mouse intestinal motility in vivo.	Gastroenterology 20050901
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.	Journal of medicinal chemistry 20050811
Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis.	The Journal of neuroscience : the official journal of the Society for Neuroscience 20041215
Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.	Journal of medicinal chemistry 20031009
Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.	Journal of medicinal chemistry 20030410
AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.	Archives of toxicology 20030401
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.	British journal of pharmacology 20010801